NICE Says No to Inhaled Insulin: What Lessons Should We Learn? Nick Freemantle Editorial 09 October 2012 Pages: 627 - 629
Economic Models of Antiretroviral Therapy Fred J. Hellinger Current Opinion 09 October 2012 Pages: 631 - 642
Developing Health-Related Quality-of-Life Instruments for Use in Asia Yin Bun CheungJulian Thumboo Current Opinion 09 October 2012 Pages: 643 - 650
Cost of Lung Cancer Laurent MolinierChristophe CombescureAlain Vergnenègre Review Article 09 October 2012 Pages: 651 - 659
Usefulness of the Audit of Diabetes-Dependent Quality-of-Life (ADDQoL) Questionnaire in Patients with Diabetes in a Multi-Ethnic Asian Country Hwee-Lin WeeChee-Eng TanShu-Chuen Li Original Research Article 09 October 2012 Pages: 673 - 682
Tapering Off Benzodiazepines in Long-Term Users Richard C. Oude VoshaarPaul F. M. KrabbeFrans G. Zitman Original Research Article 09 October 2012 Pages: 683 - 694
Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/ Fluticasone plus Salbutamol in the Treatment of Asthma Gunnar JohanssonEmma B. AndreassonClaus F. Vogelmeier Original Research Article 09 October 2012 Pages: 695 - 708
Clopidogrel Katherine A. Lyseng-WilliamsonGreg L. Plosker Adis Pharmacoeconomic Drug Evaluation 09 October 2012 Pages: 709 - 726